Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
快速解离CD19嵌合抗原受体T细胞疗法治疗复发或难治性B细胞急性淋巴细胞白血病成人患者,疗效持久且毒性低。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.00917
Roddie, Claire; Dias, Juliana; O'Reilly, Maeve A; Abbasian, Mahnaz; Cadinanos-Garai, Amaia; Vispute, Ketki; Bosshard-Carter, Leticia; Mitsikakou, Marina; Mehra, Vedika; Roddy, Harriet; Hartley, John A; Spanswick, Victoria; Lowe, Helen; Popova, Bilyana; Clifton-Hadley, Laura; Wheeler, Graham; Olejnik, Joanna; Bloor, Adrian; Irvine, David; Wood, Leigh; Marzolini, Maria A V; Domning, Sabine; Farzaneh, Farzin; Lowdell, Mark W; Linch, David C; Pule, Martin A; Peggs, Karl S
B细胞
T细胞
信号转导
白血病
T细胞
细胞生物学
毒理研究
CD19
免疫/内分泌